Supplementary Table III (online only).
Indiana University Academic Health Center protocol for prophylactic dosing of anticoagulation in severe novel coronavirus disease 2019 (COVID-19) infections
| Creatinine clearance | Weight <119 kg | Weight 120-150 kg | Weight >150 kg |
|---|---|---|---|
| >30 mL/min | Enoxaparin 30 mg q12h | Enoxaparin 40 mg q12h | Enoxaparin 60 mg q12h |
| <30 mL/min, end-stage renal disease | Heparin 5000 q8h | Heparin 7500 q8h | Heparin 7500 q8h |
q8h, Every 8 hours; q12h, every 12 hours.